Interpace Diagnostics Group Inc is engaged in developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for diagnosis and management.
Website: | www.interpacediagnostics.com |
Email: | mcarey@rxir.com |
Main Phone: | +1 844 405-9655 |
Address: | 300 Interpace Parkway |
Address 2: | Building A |
State: | NJ |
City / Town: | Parsippany |
Country: | USA |
Postal Code: | 07054 |
Exchange: | NSC |
Employees: | 65 |
NAICS: | Testing Laborato |
Last Price 0.90 | Change $ -0.0071 | Change % -0.78 | Tick N/A |
Bid 0.90 | Bid Size 1,200.00 | Ask 0.91 | Ask Size 300.00 |
Open 0.93 | High 0.93 | Low 0.90 | Prev Close 0.91 |
Last Trade | Volume 175,424 | 52 Wk Hi 3.20 | 52 Wk Low 0.72 |
Market Cap 25.1 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares 27,869,275.00 | EPS (TTM) -0.43 | PE Ratio N/A | Exchange NCM |
|
|
Last 3 Mo | Last 12 Mo | |
---|---|---|
Number of Insider Trades | 0 | 8 |
Number of Buys | 0 | 4 |
Number of Sells | 0 | 4 |
Net Activity | 0 | 379597 |
Last 10 Buys | Shares |
---|---|
Graham G. Miao | 1,000 |
Graham G. Miao | 1,000 |
Nancy Lurker | 1,000 |
Gerald R. Melillo | 1,000 |
Nancy Lurker | 1,000 |
Jeffrey E. Smith | 1,000 |
Jeffrey E. Smith | 1,000 |
Nancy Lurker | 1,000 |
Nancy Lurker | 1,000 |
Nancy Lurker | 1,000 |
Last 10 Sell | Shares |
---|---|
Gerald R. Melillo | 1,000 |
Gerald R. Melillo | 1,000 |
Gerald R. Melillo | 1,000 |
Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
---|---|---|---|---|
High Target Price Estimate | 3 | 3 | 3 | 3 |
Low Target Price Estimate | 3 | 3 | 3 | 3 |
Mean Target Price Estimate | 3 | 3 | 3 | 3 |
Standard Deviation | 0 | 0 | 0 | 0 |
Date of Most Recent Estimate | 08/24/15 | 08/24/15 | 08/24/15 | 08/24/15 |
Form Type | Form Description | Pages | Date |
---|---|---|---|
8-K | Report of unscheduled material events or corporate changes. | 12 | 2016-08-16 |
10-Q | Quarterly report with a continuing view of a company's financial position | 35 | 2016-08-15 |
8-K | Report of unscheduled material events or corporate changes. | 16 | 2016-08-08 |
DEFA14A | Additional proxy soliciting materials - definitive | 3 | 2016-07-25 |
DEFA14A | Additional proxy soliciting materials - definitive | 4 | 2016-07-21 |
DEFA14A | Additional proxy soliciting materials - definitive | 5 | 2016-07-11 |
8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-07-11 |
DEFA14A | Additional proxy soliciting materials - definitive | 3 | 2016-06-22 |
DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 65 | 2016-06-22 |
8-K/A | Amendment to a previously filed 8-K | 22 | 2016-06-22 |
Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 |
Moderate Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Moderate Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Mean Rec. | 0 | 0 | 0 | 1 |